Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ivabradine and Its Role in the Development of Atrial Fibrillation in Patients With Chronic Coronary Syndrome

NCT05168189 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05168189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05168189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ivabradine and Its Role in the Development of Atrial Fibrillation in Patients With Chronic Coronary Syndrome
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2022
Completion date
January 31, 2024
Enrollment
180 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

af - atrial fibrillation